Bluejay Diagnostics, Inc. (BJDX)
USD 3.54
(8.92%)
USD 3.54
(8.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.83 Million USD | 80.89% |
| 2022 | -9.62 Million USD | 49.48% |
| 2021 | -19.04 Million USD | -13369.09% |
| 2020 | 143.55 Thousand USD | -85.25% |
| 2019 | 973.27 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.32 Million USD | -26.66% |
| 2024 Q2 | -7.61 Million USD | -227.1% |
| 2023 Q4 | -1.83 Million USD | 60.79% |
| 2023 FY | -1.83 Million USD | 80.89% |
| 2023 Q3 | -4.68 Million USD | -0.25% |
| 2023 Q2 | -4.67 Million USD | 26.05% |
| 2023 Q1 | -6.32 Million USD | 34.18% |
| 2022 Q3 | -12.93 Million USD | 13.27% |
| 2022 Q2 | -14.91 Million USD | 11.46% |
| 2022 Q1 | -16.84 Million USD | 11.58% |
| 2022 FY | -9.62 Million USD | 49.48% |
| 2022 Q4 | -9.6 Million USD | 25.72% |
| 2021 Q1 | 912.36 Thousand USD | 535.57% |
| 2021 Q2 | 101.44 Thousand USD | -88.88% |
| 2021 Q4 | -19.04 Million USD | -1258.46% |
| 2021 Q3 | 1.64 Million USD | 1520.78% |
| 2021 FY | -19.04 Million USD | -13369.09% |
| 2020 Q4 | 143.55 Thousand USD | 0.0% |
| 2020 Q1 | 96.01 Thousand USD | 0.0% |
| 2020 FY | 143.55 Thousand USD | -85.25% |
| 2019 FY | 973.27 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 106.788% |
| BrainsWay Ltd. | -10.32 Million USD | 82.186% |
| Cerus Corporation | 84.35 Million USD | 102.179% |
| Envoy Medical, Inc. | -3.81 Million USD | 51.798% |
| electroCore, Inc. | -9.95 Million USD | 81.533% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 64.129% |
| IceCure Medical Ltd | -9.93 Million USD | 81.494% |
| Inogen, Inc. | -103.56 Million USD | 98.225% |
| OrthoPediatrics Corp. | -9.26 Million USD | 80.162% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 49.508% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 85.963% |
| MaxCyte, Inc. | -27.76 Million USD | 93.378% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 64.22% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -219.298% |
| Orthofix Medical Inc. | 96.44 Million USD | 101.906% |
| PAVmed Inc | 29.08 Million USD | 106.321% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 89.147% |
| RxSight, Inc. | -6.68 Million USD | 72.479% |
| Sight Sciences, Inc. | -102.71 Million USD | 98.21% |
| SI-BONE, Inc. | 5.72 Million USD | 132.134% |
| TELA Bio, Inc. | -3.94 Million USD | 53.446% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 103.207% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 622.276% |
| Acutus Medical, Inc. | 12.27 Million USD | 114.972% |
| Talis Biomedical Corporation | -57.06 Million USD | 96.778% |
| Spectral AI, Inc. | -3.5 Million USD | 47.489% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 96.172% |
| CVRx, Inc. | -59.95 Million USD | 96.934% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 192.655% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 243.891% |
| Bioventus Inc. | 372.51 Million USD | 100.494% |
| Venus Concept Inc. | 74.3 Million USD | 102.474% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 81.945% |
| LivaNova PLC | 62.53 Million USD | 102.94% |
| 908 Devices Inc. | -115.09 Million USD | 98.403% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 100.573% |
| Nemaura Medical Inc. | 9.92 Million USD | 118.523% |
| NeuroPace, Inc. | 54.33 Million USD | 103.383% |
| LENSAR, Inc. | -18.31 Million USD | 89.961% |
| Apyx Medical Corporation | -5.15 Million USD | 64.31% |
| Cutera, Inc. | 288.3 Million USD | 100.638% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 124.463% |
| BioSig Technologies, Inc. | 262 Thousand USD | 801.684% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 95.806% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 80.015% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.131% |
| Axonics, Inc. | -77.19 Million USD | 97.618% |
| Outset Medical, Inc. | 67.67 Million USD | 102.716% |
| IRIDEX Corporation | -4.28 Million USD | 57.127% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 98.967% |
| IRadimed Corporation | -47.71 Million USD | 96.147% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 39.246% |
| INVO Bioscience, Inc. | 8.45 Million USD | 121.753% |
| Telesis Bio, Inc. | 32.63 Million USD | 105.633% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 26.526% |
| Varex Imaging Corporation | 316.9 Million USD | 100.58% |
| Quipt Home Medical Corp. | 81.73 Million USD | 102.249% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 33.918% |
| Pulmonx Corporation | -42.36 Million USD | 95.66% |
| Dynatronics Corporation | 6.2 Million USD | 129.633% |
| Modular Medical, Inc. | -8.04 Million USD | 77.14% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 57.216% |
| Semler Scientific, Inc. | -57.13 Million USD | 96.782% |
| InMode Ltd. | -135.39 Million USD | 98.642% |
| Bruker Corporation | 891.3 Million USD | 100.206% |
| Cytosorbents Corporation | 4.18 Million USD | 143.96% |
| DexCom, Inc. | 2.02 Billion USD | 100.091% |
| Align Technology, Inc. | -840.47 Million USD | 99.781% |
| Viveve Medical, Inc. | -13.81 Million USD | 86.691% |
| ZimVie Inc. | 450.41 Million USD | 100.408% |
| Movano Inc. | -5.86 Million USD | 68.66% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 98.633% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -219.298% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 192.655% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 100.515% |
| Profound Medical Corp. | -18.17 Million USD | 89.887% |
| Insulet Corporation | 798.1 Million USD | 100.23% |
| enVVeno Medical Corporation | -2.21 Million USD | 17.114% |
| Surmodics, Inc. | -12.01 Million USD | 84.698% |
| iCAD, Inc. | -21.2 Million USD | 91.332% |
| Nuwellis, Inc. | -2.81 Million USD | 34.785% |
| Biotricity, Inc. | 23.09 Million USD | 107.961% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 101.963% |
| Aethlon Medical, Inc. | -4.5 Million USD | 59.162% |
| InspireMD, Inc. | -8.04 Million USD | 77.148% |
| PAVmed Inc. | 29.08 Million USD | 106.321% |
| BIOLASE, Inc. | 11.34 Million USD | 116.206% |
| Beyond Air, Inc. | 6.22 Million USD | 129.514% |
| FONAR Corporation | -14.66 Million USD | 87.464% |
| AxoGen, Inc. | 32.26 Million USD | 105.698% |
| Vivani Medical, Inc. | 42 Thousand USD | 4477.169% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 82.751% |
| Inari Medical, Inc. | -7.16 Million USD | 74.327% |
| UFP Technologies, Inc. | 40.77 Million USD | 104.509% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 159.91% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 61.469% |
| Tenon Medical, Inc. | -1.25 Million USD | -46.487% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 75.829% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 84.585% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.083% |
| Sintx Technologies, Inc. | 905 Thousand USD | 303.139% |
| NanoVibronix, Inc. | -3.27 Million USD | 43.917% |
| Quanterix Corporation | -132.95 Million USD | 98.617% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 33.918% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 91.78% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.244% |
| TransMedics Group, Inc. | 121.13 Million USD | 101.518% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 92.978% |
| NeuroMetrix, Inc. | -1.49 Million USD | -23.295% |
| Hyperfine, Inc. | -75.61 Million USD | 97.569% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 101.208% |
| Biomerica, Inc. | -3.38 Million USD | 45.689% |
| Bone Biologics Corporation | -3.02 Million USD | 39.258% |
| AVITA Medical, Inc. | -26.23 Million USD | 92.992% |
| Silk Road Medical, Inc | 64.42 Million USD | 102.854% |